News summary

Study on the clinical outcomes of COVID-19 infection and immune responses following the third booster dose of inactivated COVID-19 vaccine in hematologic disease patients

Source: Frontiers - Health • Published: 27 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

A single-center Chinese study found lower humoral responses and longer RT-PCR positivity in these patients.

Study on the clinical outcomes of COVID-19 infection and immune responses following the third booster dose of inactivated COVID-19 vaccine in hematologic disease patients
Key Takeaways
  • Patients with hematologic diseases have lower antibody responses.
  • Patients with hematologic diseases had longer RT-PCR positivity.
  • Observational design has not established causal vaccine effects.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?